Impax Asset Management Group
HCAT icon

Impax Asset Management Group’s Health Catalyst HCAT Stock Holding History

Impax Asset Management Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.96M Buy
4,000,000
+1,250,000
+45% +$1.8M 0.05% 184
2026
Q1 		$3.49M Hold
2,750,000
– – 0.02% 227
2025
Q4 		$6.57M Hold
2,750,000
– – 0.04% 190
2025
Q3 		$7.84M Hold
2,750,000
– – 0.05% 163
2025
Q2 		$10.4M Hold
2,750,000
– – 0.06% 138
2025
Q1 		$12.5M Hold
2,750,000
– – 0.08% 131
2024
Q4 		$19.4M Buy
2,750,000
+195,525
+8% +$1.56M 0.09% 125
2024
Q3 		$20.8M Buy
2,554,475
+360,201
+16% +$2.6M 0.08% 126
2024
Q2 		$14M Buy
2,194,274
+39,799
+2% +$255K 0.06% 140
2024
Q1 		$16.2M Buy
2,154,475
+400,000
+23% +$3.65M 0.06% 140
2023
Q4 		$16.2M Buy
1,754,475
+600,000
+52% +$4.9M 0.07% 132
2023
Q3 		$11.7M Hold
1,154,475
– – 0.05% 151
2023
Q2 		$14.4M Sell
1,154,475
-50,000
-4% -$595K 0.06% 140
2023
Q1 		$14.1M Hold
1,204,475
– – 0.06% 137
2022
Q4 		$12.8M Buy
1,204,475
+294,419
+32% +$2.84M 0.06% 143
2022
Q3 		$8.83M Buy
910,056
+100,000
+12% +$1.32M 0.05% 155
2022
Q2 		$11.7M Buy
810,056
+425,000
+110% +$7.25M 0.06% 141
2022
Q1 		$10.1M Hold
385,056
– – 0.04% 156
2021
Q4 		$15.3M Buy
385,056
+75,000
+24% +$3.42M 0.06% 137
2021
Q3 		$15.5M Buy
310,056
+75,000
+32% +$4.09M 0.06% 129
2021
Q2 		$13M Buy
235,056
+35,256
+18% +$1.88M 0.06% 131
2021
Q1 		$9.35M Sell
199,800
-200
-0.1% -$9.69K 0.05% 143
2020
Q4 		$8.71M Hold
200,000
– – 0.06% 127
2020
Q3 		$7.32M Buy
+200,000
New +$6.79M 0.06% 131

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $299M AUM 53.01% 1-Year Est. Return

Impax Asset Management Group's HCAT Position: Q2 2026 in Review

Impax Asset Management Group increased its Health Catalyst (HCAT) stake by 45% in Q2 2026, buying an estimated $1.8M and bringing the position to 4,000,000 shares worth $7.96M. The position accounts for 0.05% of the portfolio, ranked #184.

Impax Asset Management Group first reported a position in HCAT in Q3 2020 and has held it in 24 quarters since. The position peaked at $20.8M in Q3 2024. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Impax Asset Management Group held 4,000,000 shares of Health Catalyst worth $7.96M as of Q2 2026.
  • Impax Asset Management Group bought 1,250,000 Health Catalyst shares in Q2 2026, an estimated $1.8M.
  • Health Catalyst made up 0.05% of Impax Asset Management Group's portfolio in Q2 2026, its #184 holding.
  • Impax Asset Management Group first reported a position in Health Catalyst in Q3 2020 and has held it in 24 quarters since.
  • Impax Asset Management Group's Health Catalyst position peaked at $20.8M in Q3 2024.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.